(Q46142346)

19 December 2017

title

RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice (English)

1 reference

19 December 2017

1 reference

Li Sun

1

1 reference

19 December 2017

Tatsuro Ishida

2

1 reference

19 December 2017

Tomoyuki Yasuda

3

1 reference

19 December 2017

Yoko Kojima

4

1 reference

19 December 2017

Tomoyuki Honjo

5

1 reference

19 December 2017

Yasuhiko Yamamoto

6

1 reference

19 December 2017

Hiroshi Yamamoto

7

1 reference

19 December 2017

Shun Ishibashi

8

1 reference

19 December 2017

Ken-ichi Hirata

9

1 reference

19 December 2017

Yoshitake Hayashi

10

1 reference

19 December 2017

publication date

28 January 2009

1 reference

19 December 2017

published in

Cardiovascular Research

1 reference

19 December 2017

volume

82

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

371-381

1 reference

19 December 2017

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Detection of superoxide in vascular tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Innate and acquired immunity in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP036

21 January 2018

Identifiers

DOI

10.1093/CVR/CVP036

1 reference

19 December 2017

PubMed ID

19176597

1 reference

19 December 2017